ClearBridge underperformed in Q4 2022, what drove their decision to exit UnitedHealth and enter Wingstop?

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking why ClearBridge exited UnitedHealth and entered Wingstop in Q4 2022. First, I need to check the references provided. Looking at the references, there's a query about ClearBridge Energy Midstream Opportunity Fund holdings for UnitedHealth Group in Q4 2022 (Number 27) and Wingstop (Number 30). The results show that ClearBridge held UnitedHealth with a shareholding ratio of around 0.76-0.77% and Wingstop at 2.79-2.8%. But wait, the user is asking about exiting UnitedHealth and entering Wingstop. The data shows holdings in both, but does it indicate a shift from one to the other? Wait, the user's question is about exiting UnitedHealth and entering Wingstop. The references don't explicitly state that ClearBridge sold UnitedHealth and bought Wingstop. Instead, they show holdings in both. Maybe the user is assuming a shift based on the holdings, but the data doesn't confirm an exit or entry. Also, looking at the other references, there's information about UnitedHealth's Q4 2025 earnings (Numbers 2, 3, 4, 5, 24). These reports mention that UnitedHealth had a revenue miss and profit issues, leading to stock drops. However, the time frame here is 2025, not 2022. The user's question is about Q4 2022, so the 2025 data might not be relevant unless there's a long-term strategy. The user's profile shows interest in NASDAQ, which is tech-heavy. Wingstop is a restaurant chain, not tech, so maybe the user is curious about a shift in strategy. But the data doesn't show ClearBridge exiting UnitedHealth in 2022; they still held it. The Wingstop holding is new in 2022 Q4, but the exit from UnitedHealth isn't supported by the data provided. Wait, the query results for EMO Holdings in Q4 2022 (Number 1) show 0 results. So there's no data on EMO's holdings for that quarter. The other queries (Numbers 27 and 30) are about specific stocks, but they don't indicate a trade between them. Therefore, the answer should clarify that there's no explicit data showing ClearBridge exiting UnitedHealth and entering Wingstop in Q4 2022. The available data only shows holdings in both, but no transaction details. The user might be conflating different time periods or making an assumption based on later events. I need to structure the answer to address this, using the available data without assuming actions not supported by the references. Also, since the user is interested in NASDAQ, maybe mention the tech angle briefly, but the data doesn't support a direct link here. ``` **Conclusion** 🎯 Based on the available data, there is no explicit evidence that ClearBridge Energy Midstream Opportunity Fund (EMO) exited UnitedHealth Group (UNH) and entered Wingstop (WING) in Q4 2022. The data shows that EMO held both stocks in its portfolio during Q4 2022, but there is no transactional data confirming a strategic shift between the two. The decision to hold or trade these stocks would likely depend on EMO's investment strategy, which focuses on energy midstream entities and high cash distributions . --- ### **Analysis** 📊 #### 1. **ClearBridge's Portfolio in Q4 2022** The data indicates that EMO held UnitedHealth Group (UNH) with a shareholding ratio of **0.76-0.77%** and Wingstop (WING) with a shareholding ratio of **2.79-2.8%** as of December 31, 2022 . However, this does not confirm whether these positions were added or exited during the quarter. | Stock | Shareholding Ratio | Shareholder Name | Trading Date | |-------------|--------------------|---------------------------|----------------| | UNH | 0.76-0.77% | Clearbridge Investments, LLC | 2022-12-31 | | WING | 2.79-2.8% | Clearbridge Investments, LLC | 2022-12-31 | #### 2. **UnitedHealth Group's Performance Context** UnitedHealth Group faced challenges in later quarters (e.g., Q4 2025), including a **revenue miss** and **GAAP profit collapse** . However, these events occurred **post-Q4 2022**, making them irrelevant to EMO's 2022 portfolio decisions. #### 3. **Wingstop's Attractiveness** Wingstop reported **record growth** in 2022, including **13.2% unit growth** and **19th consecutive year of positive same-store sales growth** . This could align with EMO's focus on high-growth opportunities, though the fund primarily targets energy midstream entities . #### 4. **ClearBridge's Investment Strategy** EMO's strategy emphasizes **cash distributions** and **energy midstream investments** . The inclusion of non-midstream stocks like UNH and WING suggests opportunistic or diversification plays, but there is no data linking these positions to a strategic exit/entry decision in Q4 2022. --- ### **Key Takeaways** 📌 - **No Evidence of Exit/Entry**: The data does not confirm a strategic shift from UNH to WING in Q4 2022. - **Portfolio Diversification**: EMO held both stocks, possibly reflecting a mix of core midstream holdings and opportunistic plays. - **Focus on Cash Flow**: EMO's strategy prioritizes high cash distributions, which may explain its interest in stable dividend payers like UNH and growth-oriented names like WING.